CTLA4 and melanoma: An interesting observation was made by Quezada et al., who investigated the effects of anti-CTLA-4 and a GM-CSF-transduced tumor cell vaccine (Gvax) on the balance between effector T cells (Teffs) and Tregs in a mouse model of melanoma [161].